Cargando…
Conditional Lpar1 gene targeting identifies cell types mediating neuropathic pain
LPA(1) is one of six known receptors (LPA(1‐6)) for lysophosphatidic acid (LPA). Constitutive Lpar1 null mutant mice have been instrumental in identifying roles for LPA‐LPA(1) signaling in neurobiological processes, brain development, and behavior, as well as modeling human neurological diseases lik...
Autores principales: | Rivera, Richard R., Lin, Mu‐En, Bornhop, Emily C., Chun, Jerold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383719/ https://www.ncbi.nlm.nih.gov/pubmed/32929779 http://dx.doi.org/10.1096/fj.202000317R |
Ejemplares similares
-
Generation of an Lpar1-EGFP Fusion Knock-in Transgenic Mouse Line
por: Rivera, Richard, et al.
Publicado: (2021) -
Loss of spinal substance P pain transmission under the condition of LPA(1 )receptor-mediated neuropathic pain
por: Inoue, Makoto, et al.
Publicado: (2006) -
Lysophosphatidic acid (LPA)-antibody (504B3) engagement detected by interferometry identifies off-target binding
por: Ray, Manisha, et al.
Publicado: (2021) -
microRNA-329 reduces bone cancer pain through the LPAR1-dependent
LPAR1/ERK signal transduction pathway in mice
por: Wu, Xian-Ping, et al.
Publicado: (2019) -
Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain
por: Inoue, Makoto, et al.
Publicado: (2008)